European Union

Commission Implementing Regulation (EU) 2025/888 of 15 May 2025 on the registration of the geographical indication Pastel de feijão de Torres Vedras (PGI) in the Union register of geographical indications pursuant to Regulation (EU) 2024/1143 of the European Parliament and of the Council

  • Post author:
  • Post category:

COMMISSION IMPLEMENTING REGUL ATION (EU) 2024/2563 of 24 September 2024amending Implementing Regulation (EU) 2022/1646 as regards additional content of the national risk-based control plans and the national randomised sur veillance…

Continue ReadingCommission Implementing Regulation (EU) 2025/888 of 15 May 2025 on the registration of the geographical indication Pastel de feijão de Torres Vedras (PGI) in the Union register of geographical indications pursuant to Regulation (EU) 2024/1143 of the European Parliament and of the Council

Commission Implementing Regulation (EU) 2025/787 of 24 April 2025 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1,4-dimethylnaphthalene, amidosulfuron, bentazone, bixafen, clomazone, fenoxaprop-P, fludioxonil, fluoxastrobin, flutolanil, fluxapyroxad, gibberellic acid, gibberellins, halauxifen-methyl, mecoprop-P, paraffin oil, penthiopyrad, pirimiphos-methyl, propamocarb, propyzamide, prothioconazole, rimsulfuron, sedaxane and sulfoxaflor

  • Post author:
  • Post category:

COMMISSION IMPLEMENTING REGUL ATION (EU) 2024/2563 of 24 September 2024amending Implementing Regulation (EU) 2022/1646 as regards additional content of the national risk-based control plans and the national randomised sur veillance…

Continue ReadingCommission Implementing Regulation (EU) 2025/787 of 24 April 2025 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1,4-dimethylnaphthalene, amidosulfuron, bentazone, bixafen, clomazone, fenoxaprop-P, fludioxonil, fluoxastrobin, flutolanil, fluxapyroxad, gibberellic acid, gibberellins, halauxifen-methyl, mecoprop-P, paraffin oil, penthiopyrad, pirimiphos-methyl, propamocarb, propyzamide, prothioconazole, rimsulfuron, sedaxane and sulfoxaflor

Commission Implementing Regulation (EU) 2025/1176 of 23 May 2025 specifying the pre-qualification and award criteria for auctions for the deployment of energy from renewable sources

  • Post author:
  • Post category:

COMMISSION IMPLEMENTING REGUL ATION (EU) 2024/2563 of 24 September 2024amending Implementing Regulation (EU) 2022/1646 as regards additional content of the national risk-based control plans and the national randomised sur veillance…

Continue ReadingCommission Implementing Regulation (EU) 2025/1176 of 23 May 2025 specifying the pre-qualification and award criteria for auctions for the deployment of energy from renewable sources

Commission Implementing Regulation (EU) 2025/1182 of 17 June 2025 establishing detailed rules on the rescaling of harmonised indices to the common index reference period 2025 pursuant to Regulation (EU) 2016/792 of the European Parliament and of the Council

  • Post author:
  • Post category:

COMMISSION IMPLEMENTING REGUL ATION (EU) 2024/2563 of 24 September 2024amending Implementing Regulation (EU) 2022/1646 as regards additional content of the national risk-based control plans and the national randomised sur veillance…

Continue ReadingCommission Implementing Regulation (EU) 2025/1182 of 17 June 2025 establishing detailed rules on the rescaling of harmonised indices to the common index reference period 2025 pursuant to Regulation (EU) 2016/792 of the European Parliament and of the Council

Commission Implementing Regulation (EU) 2025/1234 of 25 June 2025 amending Implementing Regulation (EU) 2021/2226 as regards the medical devices for which the instructions for use may be provided in electronic form

  • Post author:
  • Post category:

COMMISSION IMPLEMENTING REGUL ATION (EU) 2024/2563 of 24 September 2024amending Implementing Regulation (EU) 2022/1646 as regards additional content of the national risk-based control plans and the national randomised sur veillance…

Continue ReadingCommission Implementing Regulation (EU) 2025/1234 of 25 June 2025 amending Implementing Regulation (EU) 2021/2226 as regards the medical devices for which the instructions for use may be provided in electronic form